• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Archives of Internal Medicine >Association of early follow-up after acute myocardial infarction with higher rates of medication use.
【24h】

Association of early follow-up after acute myocardial infarction with higher rates of medication use.

机译：协会的早期急性后随访心肌梗死与更高的利率药物使用。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

BACKGROUND: Early outpatient follow-up after acute myocardial infarction (AMI) is recommended in guidelines, but its relationship with the use of evidence-based therapies is unknown. METHODS: We evaluated 1516 patients hospitalized with AMI from the multicenter Prospective Registry Evaluating Outcomes After Myocardial Infarction: Events and Recovery registry. Early follow-up was defined as patient- reported visits with a primary care physician or cardiologist within 1 month after discharge. The primary outcomes were use of aspirin, beta-blockers, angiotensin-converting enzyme inhibitors, and statins in eligible patients at 6 months. Multivariable analyses assessed the association between early follow-up and medication use at 6 months, adjusting for patient and clinical characteristics. Secondary analyses compared medication use at 6 months for patients receiving collaborative follow-up from a single provider vs those receiving follow-up from both provider types. RESULTS: Among the cohort, 34% reported no outpatient follow-up during the month following discharge. Rates of medication prescription among appropriate candidates were similar at hospital discharge for both follow-up groups. Compared with those not receiving early follow-up, those receiving early follow-up were more likely to be prescribed beta-blockers (80.1% vs 71.3%; P = .001), aspirin (82.9% vs 77.1%; P = .01), or statins (75.9% vs 68.6%; P = .005) at 6 months. In multivariable analyses, a persistent relationship remained between early follow-up and beta-blocker use (risk ratio, 1.08; 95% confidence interval, 1.02-1.15). In secondary analyses, statin use was higher in patients receiving collaborative follow-up (risk ratio, 1.11; 95% confidence interval, 1.01-1.22). CONCLUSIONS: Early outpatient follow-up and collaborative follow-up after AMI is associated with higher rates of evidence-based medication use. Although further studies should assess whether this relationship is causal, these results support current guideline recommendations for follow-up after AMI.
机译：背景:早期急性后门诊随访心肌梗死(AMI)建议使用指南,但它的关系以证据为基础的治疗是未知的。评估1516例AMI住院多中心前瞻性的注册表心肌梗死后评估结果:事件和恢复注册表。定义为患者——报道访问初级保健医生或心脏病1月后排放。使用阿司匹林,β-阻断剂血管紧张素转换酶抑制剂他汀类药物的患者在6个月的资格。多变量分析评估了协会早期随访和药物使用6之间个月,调整患者和临床特征。药物治疗对患者使用6个月协作跟踪从单个提供商vs那些接受后续的提供者类型。在月后门诊随访放电。合适的候选人在医院中是相似的为后续组放电。与那些没有接受早期随访接受早期后续也更容易规定阻滞剂(80.1% vs 71.3%;措施),阿司匹林(82.9% vs 77.1%;他汀类药物(75.9% vs 68.6%;在多变量分析中,持久的保持早期随访和之间的关系β受体阻滞剂使用(风险比,1.08;置信区间,1.02 - -1.15)。他汀类药物分析,更高的病人接收协作跟踪(风险比,1.11;结论:早期门诊随访合作的相关后续AMI后更高的利率的循证药物使用。这种关系是否因果,这些结果支持当前的指导方针建议对AMI后随访。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号